$ANTX
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Healthcare
Sector
Biotechnology
Industry
Eric E. Easom
CEO
22
Employees
$5.41
Current Price
$29.05M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 4 | $66,972.27 | 11,127 | ||
| 2 weeks | Buys | 1 | 1 | $11,601.94 | 2,098 | 1:9.09 |
| Sells | 2 | 7 | $105,502.21 | 17,499 | ||
| 1 month | Buys | 1 | 1 | $11,601.94 | 2,098 | 1:27.43 |
| Sells | 2 | 9 | $318,204.51 | 52,901 | ||
| 2 months | Buys | 1 | 1 | $11,601.94 | 2,098 | 1:27.43 |
| Sells | 2 | 9 | $318,204.51 | 52,901 | ||
| 3 months | Buys | 1 | 1 | $11,601.94 | 2,098 | 1:29.56 |
| Sells | 3 | 10 | $343,007.05 | 58,846 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.